Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Nemaura Medical Inc. (NMRD)

2.57   -0.01 (-0.39%) 07-02 20:31
Open: 2.52 Pre. Close: 2.58
High: 2.57 Low: 2.52
Volume: 3,093 Market Cap: 62(M)
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.57 - 2.59 2.59 - 2.6
Low: 2.48 - 2.5 2.5 - 2.52
Close: 2.54 - 2.57 2.57 - 2.59

Technical analysis

as of: 2022-07-01 4:23:58 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.28     One year: 3.5
Support: Support1: 2.51    Support2: 2.09
Resistance: Resistance1: 2.81    Resistance2: 3
Pivot: 2.66
Moving Average: MA(5): 2.64     MA(20): 2.7
MA(100): 3.5     MA(250): 4.88
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 8.9     %D(3): 15.1
RSI: RSI(14): 41.2
52-week: High: 9.68  Low: 2.15
Average Vol(K): 3-Month: 6 (K)  10-Days: 4 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ NMRD ] has closed above bottom band by 21.2%. Bollinger Bands are 54.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 30 Jun 2022
Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022 - Yahoo Finance

Wed, 22 Jun 2022
Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding - GuruFocus.com

Thu, 19 May 2022
Nemaura Medical to Present at the HC Wainwright Global Hybrid Investment Conference - GlobeNewswire

Tue, 03 May 2022
MySugarWatch Launches Physician-Focused Ads in MIMS As Part of Large-Scale Awareness Campaign Around Nemaura Medical’s sugarBEAT Non-Invasive Continuous Glucose Monitor - Yahoo Finance

Thu, 10 Mar 2022
Nemaura Medical: Opportunity In The Continuous Glucose Monitoring Market - Seeking Alpha

Mon, 28 Feb 2022
Nemaura Medical Wins Innovation Awards - GlobeNewswire

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 0 (M)
Shares Float 23 (M)
% Held by Insiders 9.93e+006 (%)
% Held by Institutions 58.7 (%)
Shares Short 166 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -6.34e+006
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -3
Return on Assets (ttm) 543.7
Return on Equity (ttm) -18.2
Qtrly Rev. Growth 183630
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.25
Qtrly Earnings Growth -0.5
Operating Cash Flow 0 (M)
Levered Free Cash Flow -6 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -0.14

Stock Dividends

Dividend 0
Forward Dividend 139970
Dividend Yield 0%
Dividend Pay Date 2019-12-04
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.